HRAS overexpression

News alerts, weekly reports and conference planners

Entrez ID:

Related biomarkers:

HRAS overexpression	Neuroendocrine Tumor	HRAS overexpression	Neuroendocrine Tumor	lenvatinib Sensitive: C3 – Early Trials lenvatinib Sensitive : C3	lenvatinib Sensitive: C3 – Early Trials lenvatinib Sensitive : C3
HRAS overexpression	Squamous Cell Carcinoma of Head and Neck	HRAS overexpression	Squamous Cell Carcinoma of Head and Neck	alpelisib + tipifarnib Sensitive: C3 – Early Trials alpelisib + tipifarnib Sensitive : C3	alpelisib + tipifarnib Sensitive: C3 – Early Trials alpelisib + tipifarnib Sensitive : C3

Associations